Evaluating cytotoxic effect of nanoliposomes encapsulated with umbelliprenin on 4T1 cell line

Cytotoxicity of umbelliprenin has been found in various cancer cell lines such as, prostate, breast, CLL, and skin. Encapsulating chemotherapeutic agents with nanoliposomes have been resulted in improved cytotoxicity effects than their free forms. However, whether nanoliposomal form of umbelliprenin...

Full description

Saved in:
Bibliographic Details
Published in:In vitro cellular & developmental biology. Animal 2017-01, Vol.53 (1), p.7-11
Main Authors: Rashidi, Mohsen, Ahmadzadeh, Alireza, Ziai, Seyed Ali, Narenji, Mahsa, Jamshidi, Hamidreza
Format: Article
Language:English
Subjects:
Animal Genetics and Genomics
Animals
Biomedical and Life Sciences
BIOTECHNOLOGY
Cell Biology
Cell Culture
Cell Death - drug effects
Cell Line, Tumor
Cell Proliferation - drug effects
Cell Survival - drug effects
Chemistry, Pharmaceutical
Chromatography, High Pressure Liquid
Developmental Biology
Inhibitory Concentration 50
Life Sciences
Liposomes - toxicity
Mice
Nanoparticles - toxicity
Stem Cells
Umbelliferones - chemistry
Umbelliferones - pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cytotoxicity of umbelliprenin has been found in various cancer cell lines such as, prostate, breast, CLL, and skin. Encapsulating chemotherapeutic agents with nanoliposomes have been resulted in improved cytotoxicity effects than their free forms. However, whether nanoliposomal form of umbelliprenin could have higher cytotoxic effect than free umbelliprenin is not clarified yet. After synthesizing umbelliprenin, different concentrations (3, 6, 12, 25, 50, 100, 200 μg/ml) applied on the mouse mammary carcinoma cell line (4T1) for 24, 48, and 72 h at 37°C. Afterwards, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was performed to analyze cytotoxicity. MTT assay results showed that IC50 of umbelliprenin in dimethyl sulfoxide (DMSO) (30.92, 30.64, and 62.23 for 24,48, 72 h incubation, respectively) decreased (5.8, 5.0, 3.5 for 24, 48, 72 h incubation, respectively) when encapsulated with nanoliposomes. Nanoliposomal umbelliprenin cytotoxicity affected cell viability in concentration and time-dependent manner. Our study recommended nanoliposomal umbelliprenin as the most effective chemotherapeutic agent against the mouse mammary carcinoma cell line viability. Future in vivo studies and clinical trials are needed.
ISSN:1071-2690
1543-706X
DOI:10.1007/s11626-016-0080-7